GOP lawmakers push Trump's FDA to preserve diversity requirements in clinical trials

Republican members of Congress are urging the Trump administration's FDA to ensure clinical trials remain diverse in terms of participant demographics, after references to DEI were purged from Health and Human Services websites shortly after Trump took office. Supporters argue clinical trial diversity is not about hiring or social policy, but about making sure drugs and devices are tested on patients who represent future users. The effort marks an unusual push from within the GOP to walk back part of the administration's anti-DEI sweep.

More on this topic

🌍 World Senator Lindsey Graham Honored at Capitol Funeral: 'Full Measure of a Mighty Heart' Onet Wiadomości · 22h ago 🏥 Health FDA questions efficacy of Capricor's Duchenne muscular dystrophy drug STAT News · 2d ago 🌍 World Whereabouts of ~$13 bn from Venezuelan oil deal unclear, Republicans ask questions Interia Fakty · 6d ago

More on this topic

🌍 World Senator Lindsey Graham Honored at Capitol Funeral: 'Full Measure of a Mighty Heart' Onet Wiadomości · 22h ago 🏥 Health FDA questions efficacy of Capricor's Duchenne muscular dystrophy drug STAT News · 2d ago 🌍 World Whereabouts of ~$13 bn from Venezuelan oil deal unclear, Republicans ask questions Interia Fakty · 6d ago